newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Update of Previously Announced CMS Billing Policy Impacting its Thyroid Tests

PARSIPPANY, NJ, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX:IDXG) ("Interpace" or the "Company"), a leader in enabling personalized medicine, announced today that the National Correct Coding Initiative (NCCI) program issued a r